The global clinical laboratory tests market is anticipated to grow at a CAGR of 8.60% during the forecast period of 2025–2034, driven by the increasing prevalence of chronic diseases and rising healthcare costs across the globe.
Base Year
Historical Period
Forecast Period
The growing demand for personalized medicine and targeted therapies is driving innovation in clinical laboratory testing, especially in oncology, infectious diseases, and genetic profiling.
Technological advancements such as AI integration and automation are improving test accuracy, reducing turnaround times, and expanding testing capabilities in both hospital and independent laboratory settings.
The increasing prevalence of chronic and infectious diseases worldwide is boosting routine and specialzed testing volumes, particularly in emerging markets with improving healthcare infrastructure and diagnostic access.
Value in USD Billion
2025-2034
Clinical Laboratory Tests Market Outlook
*this image is indicative*
Clinical laboratory tests are diagnostic procedures conducted on blood, urine, tissue, or other bodily fluids to detect, diagnose, monitor, or rule out diseases and medical conditions. These tests are essential for guiding treatment decisions, tracking disease progression, and ensuring preventive healthcare. They encompass a wide range of analyses, including biochemical, microbiological, immunological, haematological, and molecular tests. Performed in hospitals, diagnostic labs, and research facilities, these tests play a vital role in patient care and medical research, helping healthcare providers make informed, evidence-based clinical decisions for improved outcomes.
Rising Demand for Personalized Oncology Solutions Enhancing Market Development
The rising demand for personalized oncology care and increasing reliance on non-invasive diagnostic techniques are significantly supporting the market. For instance, in February 2025, Labcorp introduced Labcorp® Plasma Complete, a ctDNA-based comprehensive genomic profiling solution for advanced solid tumour patients. This liquid biopsy test detects genomic alterations across 521 genes, offering actionable insights using a simple blood draw. Covering FDA-approved biomarkers and treatment pathways, the test enables oncologists to make evidence-based treatment decisions. Its clinical availability is poised to accelerate the shift toward non-invasive diagnostics and drive growth in the global clinical laboratory tests market during the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in AI-Driven Detection to Support Clinical Laboratory Testing Market Value
The growing prevalence of hospital-acquired infections and the urgent need for rapid diagnostic solutions are intensifying innovations in clinical laboratory tests. For instance, in November 2024, researchers at Seoul National University developed an AI-based laboratory test to swiftly detect sepsis, a severe and potentially fatal blood infection. Unlike traditional culture methods that require days, this AI-powered solution significantly shortens diagnosis time, allowing prompt treatment. This advancement aligns with global efforts to enhance sepsis outcomes and reduce mortality rates. Such innovation is poised to bolster the clinical laboratory tests market by enabling faster decision-making, increasing test efficiency, and improving patient survival rates throughout the forecast period.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Global Clinical Laboratory Tests Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Market Breakup by Category
Market Breakup by Patient Type
Market Breakup by Service Provider
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Complete Blood Count to Dominate the Segmentation by Test Type
Complete blood count (CBC) is expected to lead the market by test type due to its broad diagnostic utility, affordability, and routine clinical application. This test helps detect a wide range of disorders, including infections, anaemia, and leukaemia, making it indispensable across all patient demographics. Rising prevalence of chronic diseases and infections, especially post-pandemic, has significantly increased the demand for CBC testing. The segment is further driven by technological advancements in automated haematology analysers that allow rapid, high-throughput testing. As healthcare systems prioritise early disease detection, CBC testing is set to remain the cornerstone of routine diagnostics, ensuring continued market dominance.
Clinical Chemistry to Lead the Clinical Laboratory Tests Market Segmentation by Category
Clinical chemistry is poised to hold the largest share by category, primarily due to the growing incidence of metabolic disorders, cardiovascular conditions, and liver diseases. This segment encompasses tests like liver function, kidney function, lipid profiles, and glucose monitoring, which are critical for routine health assessments and chronic disease management. For instance, the American Cancer Society has projected around 42,240 new cases and 30,090 deaths from liver and intrahepatic bile duct cancer in the United States in 2025, intensifying demand for liver panel diagnostics. Rising health awareness, ageing populations, and lifestyle-related illnesses have significantly boosted test volumes. Advancements in automation and reagents further support the segment’s sustained and dominant market growth.
Adult Segment to Hold a Significant Clinical Laboratory Tests Market Share by Patient Type
The adult segment is expected to lead the market by patient type due to the high burden of lifestyle and age-related illnesses, particularly diabetes, hypertension, and cardiovascular diseases. Adults, especially those aged 30 to 60, frequently undergo diagnostic tests for disease management and prevention. According to IDF projections , by 2050, 1 in 8 adults approximately 853 million adults will be living with diabetes, a 46% increase. This growing prevalence drives testing demand. Additionally, heightened awareness of preventive screenings, employer-sponsored wellness programmes, and personalised healthcare approaches further boost utilisation, positioning the adult segment as a key contributor to sustained clinical laboratory test market growth.
Hospital-Based Laboratories to Lead the Segmentation by Service Provider
Hospital-based laboratories are expected to dominate the market as service providers due to their comprehensive test offerings, integration with inpatient and emergency services, and access to advanced diagnostic technologies. These facilities typically handle high volumes of urgent and specialised tests, supported by multidisciplinary clinical teams. They benefit from established infrastructure, accreditation, and the ability to perform complex testing, such as molecular diagnostics and genetic screening. With the rising number of hospital admissions and chronic disease cases, hospital-based labs are essential for timely diagnostics and treatment planning. Their central role in both routine and critical care ensures they remain the market leader.
North America is poised to hold the largest market share in the clinical laboratory testing market, primarily due to its advanced healthcare infrastructure, rapid adoption of novel diagnostic technologies, and high prevalence of chronic and lifestyle-related diseases. The United States leads with strong regulatory frameworks, increased health screening initiatives, and growing investments in precision medicine and digital pathology. Moreover, favourable reimbursement policies and the presence of major diagnostic players contribute to the region’s dominance. Europe follows closely, driven by ageing populations and public health efforts. Asia-Pacific is emerging rapidly due to rising healthcare access and investments in diagnostics, while Latin America and the Middle East and Africa show steady growth, albeit hindered by infrastructure and economic challenges.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1967 and headquartered in Secaucus, New Jersey, Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and services. The company offers a comprehensive portfolio of clinical laboratory services, ranging from routine blood work to advanced molecular diagnostics. In March 2023, Quest launched an Expanded Test Panel post-COVID-19, featuring CBC, BMP, and hepatic function panels, addressing both residual health effects and broader preventive care. This initiative reflects Quest’s commitment to empowering patients through accessible testing, facilitating early detection, and enabling informed healthcare decisions in collaboration with providers.
Established in 1888 and headquartered in Abbott Park, Illinois, Abbott is a global healthcare leader with operations in diagnostics, medical devices, nutrition, and branded generic medicines. Its diagnostics division delivers a wide array of clinical laboratory instruments, assays, and point-of-care tests. Abbott's technologies help identify a broad spectrum of conditions, from infectious diseases to chronic illnesses, significantly advancing personalised medicine. Its innovation in laboratory diagnostics, including immunoassays and haematology solutions, supports hospitals and laboratories globally in achieving faster, more accurate diagnoses and optimised patient care.
Cinven is a leading international private equity firm founded in 1977 and headquartered in London, UK. Though not a direct diagnostics provider, Cinven plays a crucial role in the clinical laboratory testing market through strategic investments. In recent years, Cinven has acquired and backed diagnostics-focused companies, facilitating their expansion and digital transformation. These investments allow diagnostic companies to innovate and scale their operations efficiently, enhancing the accessibility and affordability of laboratory services. Cinven’s involvement underscores the growing influence of private equity in advancing global healthcare infrastructure and diagnostic service capabilities.
Founded in 1971 and headquartered in Burlington, North Carolina, Labcorp is one of the largest clinical laboratory networks worldwide. The company provides comprehensive diagnostics, drug development, and laboratory testing services. Labcorp’s vast portfolio includes routine tests, genomic analyses, and biomarker development, supporting clinical decision-making across diverse medical disciplines. With continued innovation in liquid biopsy, molecular testing, and decentralised diagnostics, Labcorp enhances early disease detection and treatment monitoring. Its expansive global footprint and collaborations with healthcare providers and biopharmaceutical companies underscore its vital role in shaping the future of precision diagnostics.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include ARUP Laboratories, OPKO Health, Inc., UNILABS, Clinical Reference Laboratory, Inc., Synnovis Group LLP, and Sonic Healthcare Limited.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Category |
|
| Breakup by Patient Type |
|
| Breakup by Service Provider |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share